Research Article
The Use of Antifibrotic Recombinant nAG Protein in a Rat Liver Fibrosis Model
Table 3
The staging of liver fibrosis in the two experimental groups.
| Degree of Fibrosis | Group II: CCL4 only | Group III: CCL4 and nAG | (n=15 rats) | (n=15 rats) |
| No or mild fibrosis | 2 (both rats had mild fibrosis) | 9 (3 rats had no fibrosis and 6 rats had mild fibrosis) |
| Moderate to severe fibrosis | 13 (4 rats had moderate fibrosis and 9 rats had severe fibrosis) | 6 (4 rats had moderate fibrosis and 2 rats had severe fibrosis) |
|
|
P= 0.008.
|